- Akebia Therapeutics (NASDAQ:AKBA) Q2 results: Revenues: $0; Net Loss: ($7.6M) (-169.2%); Loss Per Share: ($0.39) (+99.6%); Quick Assets: $124.2M (+282.2%).
- No financial guidance given.
More on Akebia Q2 results
Recommended For You
More Trending News
About AKBA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
AKBA | - | - |
Akebia Therapeutics, Inc. |